BreezeMeds vs bmiMD: Pricing, meds, and delivery comparison
Quick verdict: BreezeMeds emphasizes multiple GLP-1 options including injectable and oral semaglutide and tirzepatide with pricing starting at $199, while bmiMD focuses on compounded tirzepatide with multi month plans that bring the price as low as $139/month and free shipping. Choose based on whether you prioritize a broader medication menu or lower long term monthly price and free shipping.
See BreezeMeds pricing and options
BreezeMeds vs bmiMD: what differs most
This comparison uses the captured evidence to highlight the most distinctive differences between BreezeMeds and bmiMD so you can decide quickly. The key differences supported by the source are medication variety and formats, listed starting prices and billing options, compounded medication status and regulatory notes, and shipping and subscription terms.
1. Medication variety and formats
BreezeMeds lists semaglutide injection and tirzepatide injection plus oral semaglutide and oral tirzepatide. bmiMD centers on compounded tirzepatide only. Both notes state treatment is available only when a licensed clinician determines it is medically appropriate.
View bmiMD tirzepatide options
2. Pricing structure and billing commitments
BreezeMeds shows multiple starting prices with semaglutide injection from $199/mo; tirzepatide injection from $299; and oral options displayed from $399. A separate $169 figure appears without a clear product association. bmiMD publishes tirzepatide pricing by plan: $179 month to month; $159/mo for a three month plan; $149/mo for six months; and $139/mo for a 12 month plan. bmiMD advertises lower long term monthly equivalents with multi month commitments.
3. Compounding and regulatory notes
Both sources include a regulatory caution. BreezeMeds notes that compounded medications, when offered, are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. bmiMD states compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. Both also state treatment is available only when a licensed clinician determines it is medically appropriate.
4. Shipping, refunds, and clinician access
BreezeMeds highlights discreet home delivery and ongoing support, with language about discreet shipping to your door. bmiMD promotes free subscription shipping on every order, online refills and delivery, and 24/7 clinician access. bmiMD also includes a claim of a refund if not eligible for the program as captured on the landing page evidence.
Side by side comparison table
| Criteria | BreezeMeds | bmiMD |
|---|---|---|
| Starting price | Semaglutide injection from $199/mo; tirzepatide injection from $299; oral options from $399; a $169 figure appears without clear association | Tirzepatide: $179 month to month; $159/mo 3 month; $149/mo 6 month; $139/mo 12 month |
| Medication formats | Semaglutide injection, tirzepatide injection, oral semaglutide and oral tirzepatide | Compounded tirzepatide (GLP-1/GIP) |
| Compounded / FDA status | Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
| Shipping and delivery | Discreet home delivery; discreet shipping to your door with ongoing support | Free subscription shipping on every order; online refills and delivery |
| Billing and commitments | Pricing presented with multiple starting points; fees and billing commitments were not fully visible | Four billing options with lower long term monthly equivalent; lowest price requires a 12 month commitment |
| Clinician access and eligibility | Treatment available only when a licensed clinician determines it is medically appropriate | Treatment available only when a licensed clinician determines it is medically appropriate; 24/7 clinician access noted |
How evidence supports each provider
BreezeMeds is supported by captured landing page evidence listing multiple GLP-1 options and repeated statements about starting prices and discreet shipping. bmiMD is supported by captured landing page evidence emphasizing compounded tirzepatide with multi month plans, specific monthly rates as low as $139 for a 12 month plan, free shipping, and online refills.
Check BreezeMeds clinician review and offers
BreezeMeds vs bmiMD: final guidance
Primary keyword: BreezeMeds vs bmiMD
Choose BreezeMeds if you want access to multiple GLP-1 formats including injectable and oral semaglutide and tirzepatide and value discreet home delivery, keeping in mind starting prices shown like semaglutide injection from $199/mo and the need to confirm compounding and FDA status when relevant.
Compare bmiMD plan pricing now
Choose bmiMD if your priority is lower long term monthly cost with multi month plans for compounded tirzepatide, explicit plan pricing down to $139/mo for a 12 month plan, free subscription shipping, and online refills. In all cases confirm eligibility, total cost, renewal terms and state availability before enrollment, and remember that compounded medications are not FDA approved.